跳至主要内容
临床试验/ChiCTR1900026247
ChiCTR1900026247
尚未招募
早期 1 期

The feasibility and effects of mindfulness based relapse prevention (MBRP) on reducing craving and addictive behaviour in substance abuse disorders

Beat Drugs Fund Association1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年9月10日最近更新:

概览

阶段
早期 1 期
状态
尚未招募
发起方
Beat Drugs Fund Association
入组人数
80
试验地点
1
主要终点
Substance Use Calender (self-report)

概览

简要总结

  1. To evaluate the feasibility of using mindfulness- based relapse prevention (MBRP) programme among adults with substance abuse in Hong Kong;
  2. To examine the changes of craving, substance use, mood symptoms, self-efficacy, acceptance, level of mindfulness and quality of life between those who have enrolled in the MBRP as compared to those in the usual care control group;
  3. To evaluate the correlations between changes in substance use and craving and changes in mood symptoms, self-efficacy, acceptance, level of mindfulness, and quality of life; and
  4. To study participants characteristics related to adherence and benefits associated with MBRP

研究设计

研究类型
干预性研究
主要目的
随机平行对照
盲法
None

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • Aged between 18 and 70 years;
  • Fluent in Cantonese;
  • Has fulfilled the Structured Clinical interview for DSM(SCID) for substance use disorder diagnoses;
  • Has completed outpatient or inpatient treatment for substance abuse in the previous 6 months.

排除标准

  • Inability to provide valid consent;
  • Current or lifetime psychotic disorder diagnosed by the Structured Clinical interview for DSM-IV or DSM-5 - Imminent suicidal risk;

研究组 & 干预措施

Experimental group

MBRP intervention

Control group

Usual Care

结局指标

主要结局

Substance Use Calender (self-report)

时间窗: baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention

Urine test

时间窗: baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention

次要结局

  • Drug Craving (Penn Alcohol Craving Scale)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Depression (PHQ-9)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Anxiety (GAD-7)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Addiction Severity (Addiction Severity Index - Lite Version)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Drug Avoidance Self-Efficacy (Drug Avoidance Self-Efficacy Scale)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Level of Acceptance (Acceptance and Action Questionnaire)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Level of Mindfulness (Five Facet Mindfulness Questionnaire)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Meditation Practice (worksheet reporting type and duration of mindfulness practice)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Health Related Quality of Life (EuroQol Eq-5D-5L)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)
  • Interview (one hour, open ended questions on perceived practice of mindfulness course)(baseline, post intervention, 3 months post intervention, 6 months post intervention, 9 months post intervention, 12 months post intervention)

研究者

发起方
Beat Drugs Fund Association

研究点 (1)

Loading locations...

相似试验